Evaluation of mesotherapeutic injections of three different combinations of lipolytic agents for body contouring.

Zekayi Kutlubay

Journal: Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology 2011;13(4):142-53

PMID: 21718184

Abstract

BACKGROUND

There has been significant interest recently in the technique of mesotherapy as a method of 'melting fat' for body contouring.

OBJECTIVE

The aim of this study was to evaluate the safety, efficacy and lipolytic potential of several compounds commonly used in cosmetic mesotherapy.

METHODS

A total of 75 women (mean age: 33 years) were separated randomly into three mesotherapy groups. Injections were performed for 15 treatments once a week. The main component of each cocktail was phosphatidylcholine/deoxycholic acid for group 1, caffeine for group 2, and Conjonctyl® for group 3. Outcome was evaluated by weight, body fat percentage (BFP), circumference measurements, and patient questionnaires.

RESULTS

Seventy-two of all the patients (96%) showed a circumference loss. An average circumference reduction of 4.41 cm per site for group 1, 2.99 cm for group 2, and 2.10 cm for group 3 was achieved. Mean body circumference loss was statistically significant, with p < 0.00. Weight loss was 5.33 ± 1.09 kg for group 1, 3.74 ± 1.51 kg for group 2, and 2.82 ± 1.43 kg for group 3. Seventy-four subjects (98.7%) showed a BFP decrease. A questionnaire indicated high patient satisfaction (63%). No patient showed irregularities, dimples or any serious side effects after treatment.

CONCLUSION

Mesotherapy is a well-tolerated and effective alternative treatment modality for reducing the diameter of body circumference.

Address: Lazerart Clinics, Division of Dermatology, Istanbul, Turkey. [email protected]

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.